Market Strength Allocation Select Portfolio Series 59 (FOTMGX) 시세

Your statement is 100% not true and misleading
The management put out a statement no R/S

Why late comers and flippers who sold think RDAR value is too much for cheapo traders
Posts 2021 style trading

Yeah we get it

NeXT impending doom a

Longtime no see

Ask Tony if he's dumping and get back to us.

That makes sense.

Storyville - Good Day For The Blues live

https://www.youtube.com/watch?v=Wu3vkHwxEaE

$RELT - iQSTEL Announces Strategic Partnership with ONAR (Stock Symbol :RELT) to Elevate Market Position and Drive Investor Growth Through Rebranding https://finance.yahoo.com/news/iqst-iqstel-announces-strategic-partnership-110000628.html

GDVM chart says we are in the right place. Close to crossing MA(50) since last September, MACD in reset, bear PSAR near possible flip to cover and Swing Traders may notice our exhaustion gap up.
~~ It is about time the TREND and MOMO indicators start backing up VOLUME MONEY that has been scr

$RELT - iQSTEL Announces Strategic Partnership with ONAR (Stock Symbol :RELT) to Elevate Market Position and Drive Investor Growth Through Rebranding https://finance.yahoo.com/news/iqst-iqstel-announces-strategic-partnership-110000628.html

I agree!!


I am very positive on a positive outcome for L.

Being prepared for numerous outcomes is a shrewd decision.


Something to think about....

Here are some companies that might face increased competition if DCVax-L rec

A few more greens than reds now, but today still cannot be mistaken for a rally..

like I said for years----the MMS indeed control stocks in these pink sewers....it will run when they are heavily LOADED

HIGH RISK!!!
Matinas BioPharma Holdings, Inc. (MTNB) : 0.51
I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sh

🤣 ...55/.56 break going to be big!

New Year will just bring more DILUTION according to your overview! Add more dilution next year on top of the 3.9 BILLION Shares diluted since September!

PSRU IS A SCAM , YOU KNOW THIS..... Xavier Mitchell, and YOU, are WANNABE's!!!!


.

HIGH RISK!!!
Matinas BioPharma Holdings, Inc. (MTNB) : 0.51
I think a end value of 2.5 – 3 is possible If they find a buyer for MAT2203

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sh

Yes, we now know that MjLink buy in was just a scam that Ken ran.

$HNOI - "This teaming agreement solidifies a partnership that combines HNO's innovative hydrogen solutions with PHC's exceptional integration, distribution, and service expertise," said Don Owens, Chairman of HNO International. "Together, we are taking a significant step forward in advancing the hyd

$HNOI - "This teaming agreement solidifies a partnership that combines HNO's innovative hydrogen solutions with PHC's exceptional integration, distribution, and service expertise," said Don Owens, Chairman of HNO International. "Together, we are taking a significant step forward in advancing the hyd

$ACGX Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-133000169.html

$ACGX Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-133000169.html

The goalpost of buying/selling a stock is to make money unless you are an idiot.

Reading is fun.

https://www.otcmarkets.com/stock/RDAR/news/Raadr-Inc-Announces-Agreement-with-Shareholders-for-the-Cancellation-of-17-Billion-Common-Shares-and-Affirms-No-Reverse-?id=456191

Knife

Bristol-Myers: FDA approves nivolumab and hyaluronidase-nhy for subcutaneous injection
11:32 AM ET 12/27/2024 | Briefing.com
BMY
"On December 27, 2024, the Food and Drug Administration approved nivolumab and hyaluronidase-nhy (Opdivo Quantig, Bristol
Myers Squibb Company)

Please tell me you were looking in the mirror when you made that statement 💯🤣